FIF supports Fluosphera, Kylys Aesthetics and Consulto

The FIF is the instrument for fostering innovation and scale up of promising companies from the Canton of Geneva at the service of the United Nations (UN) Sustainable Development Goals (SDGs). The FIF is supported by the State of Geneva, the Geneva
Chamber of Commerce (CCIG), the United Nations International Trade Center (ITC) and the United Nations Environment agency.

Seed loan of 100,000 CHF awarded to Fluosphera SA

FluoSphera is a spin-off from the University of Geneva, active in the field of Life Sciences. FluoSphera develops a new generation of multi-tissue test systems using the precision of fluorescent light to mimic communications between human organs. This allows better prediction of the toxicity and safety of compounds (drugs, chemicals, cosmetics, etc.) in order to better protect patients and consumers.

Seed loan of 100,000 CHF awarded to Kylys Aesthetics SA

KYLYS Aesthetics SA is a Life Science Spin-off from the University of Geneva founded in April 2023. KYLYS AESTHETICS SA develops a next generation of hyaluronan-based dermal fillers based on modified Hyaluronic Acid molecules. With this technology, the gel can be injected with a needle of 34 Gauge (0.160 mm of external diameter), a needle ~2.7 times thinner than what is currently possible in the market.

Grant of CHF 50,000 awarded to Consulto

Consulto is a project coming from the EPFL Digital Epidemiology Lab. Based at Campus Biotech in Geneva, Consulto builds the world's first virtual clinic specialized in team-based care. They host independent doctors, generalists, and specialists, who team up to deliver holistic care for their patients. In achieving their mission, they aim to make the health care journey of people with complex health needs easy, coordinated and efficient, whenever interaction between different health professionals is required.

The next deadline to apply for the FIF is June 1st, 2023. Learn more and apply today.

(Press release / ES)
Photo: KYLYS AESTHETICS team L-R: Dr. Alexandre Porcello (CTO), Dr. Olivier Jordan (CSO), Bryan Porcello, CFA (CEO) and Prof. Eric Allémann (Scientific Advisor)